已收盤 02-06 16:00:00 美东时间
+1.510
+1.80%
U.S. Physical Therapy, Inc. ("USPH") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced a 10-year strategic alliance
02-02 20:35
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $103 price target.
01-05 23:31
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition
01-05 20:35
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
2025-11-25 10:27
JP Morgan analyst Benjamin Rossi maintains US Physical Therapy (NYSE:USPH) with a Overweight and lowers the price target from $110 to $100.
2025-11-24 23:30
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.66 per share which missed the analyst consensus estimate of $0.67 by 1.49 percent. This is a 4.35 percent decrease over earnings of $0.69 per share from
2025-11-06 06:04
今日重点评级关注:Needham:上调爱美医疗评级至"买入",目标价14美元;高盛:维持Roivant Sciences"买入"评级,目标价从20美元升至24美元
2025-09-19 09:18
J.P. Morgan upgraded Aveanna Healthcare (NASDAQ:AVAH) to Neutral from Underweight and raised its Dec. 26 price target to $10 from $6 on Thursday, noting a balanced risk-reward setup for the home healt...
2025-09-19 00:20
JP Morgan analyst Benjamin Rossi assumes US Physical Therapy (NYSE:USPH) with a Overweight rating and announces Price Target of $110.
2025-09-18 19:07